The largest database of trusted experimental protocols

Hiseq platform

Manufactured by Agilent Technologies

The HiSeq platform is a high-throughput DNA sequencing system designed for large-scale genomic applications. It utilizes sequencing-by-synthesis technology to generate high-quality sequencing data. The HiSeq platform is capable of producing large amounts of sequence data efficiently and accurately.

Automatically generated - may contain errors

3 protocols using hiseq platform

1

Prognostic Role of miR-21 in LGG and GBM

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-21 expression data and the clinical data of the LGG patients and the GBM patients were obtained from the TCGA database. MiR-21 expression was measured by Illumina Hi-Seq platform in the LGG dataset and Agilent 8 × 15 K Human microRNA platform in the GBM dataset. The inclusion criteria for the patients in the LGG and GBM datasets were as follows: (a) miR-21 expression level data and the corresponding follow-up data were available; (b) the OS or PFS were ≥ 30 days; and (c) clinical data of the patients, such as age at diagnosis, gender, tumor grade, and KPS, were available. The high- and low-expression groups were distinguished by the median value of the miR-21 expressions. Unpaired t test and chi-square test were used for the comparison of high miR-21 expression group and low miR-21 expression group. The survival curves were estimated by the Kaplan–Meier method. Survival differences between the high-expression group and the low-expression group were assessed by a log-rank test. A multivariate Cox regression analysis was used to identify miR-21 expression as an independent prognostic biomarker. All the statistical analyses were performed using PASW Statistics Version 18.0 (SPSS Inc., Chicago, Illinois, USA).
+ Open protocol
+ Expand
2

Genetic Analysis of Cerebral Small Vessel Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the index patient, a panel of 26 cerebral small vessel disease-associated genes (Supplementary Material, Table S1) was sequenced by the Leiden Laboratory for Diagnostic Genome Analysis using the Illumina HiSeq platform with the Agilent SureSelectXT Clearseq inherited disease panel target enrichment kit. The complete coding sequence was analysed, including 20 nucleotides in the flanking introns. In the other family members, the presence of the NOTCH3 variant was determined using Sanger sequencing. NOTCH3 transcript (NM_000435.2) was used as reference. The identified NOTCH3 variant was submitted to the Leiden Open Variant Database (lovd.nl/notch3) (25 (link)).
+ Open protocol
+ Expand
3

16S rRNA Gene Sequencing of Fecal Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Beijing Genomics Institute (BGI) performed the 16S rRNA gene sequencing. DNA from fecal pellets collected from APL patience was amplified using primer 515F (5′-GTGCCAGCMGCCGCGGTAA-3′) and 806R (5′-GGACTACHVGGGTWTCTAAT-3′) to target the V4 regions of 16S rRNA of bacteria. PCR reaction was carried out with 30 ng DNA samples and primers. The PCR amplification products were purified by Agencourt AMPure XP magnetic beads, and labeled, and then library building was completed. The range and concentration of fragments in the library and qualified libraries sequencing based on inserted fragment size were measured by Agilent 2100 Bioanalyzer and HiSeq platform. The 16s sequencing data were deposited in NCBI with Submission ID: SUB12873522, BioProject ID: PRJNA935705 (Raw sequence reads project Accession: PRJNA935705) with link https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA935705 (accessed on 27 February 2023).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!